[1] |
Mckee AC,Daneshvar DH. The neuropathology of traumatic brain injury[J]. Handb Clin Neurol, 2015, 127: 45-66.
|
[2] |
Mazzeo AT,Filippini C,Rosato R, et al. Multivariate projection method to investigate inflammation associated with secondary insults and outcome after human traumatic brain injury: a pilot study[J]. J Neuroinflammation, 2016, 13(1): 157.
|
[3] |
Bleriot C,Lecuit M. The interplay between regulated necrosis and bacterial infection[J]. Cell Mol Life Sci, 2016, 73(11-12): 2369-2378.
|
[4] |
Takemoto K,Hatano E,Iwaisako K, et al. Necrostatin-1 protects against reactive oxygen species (ROS)-induced hepatotoxicity in acetaminophen-induced acute liver failure[J]. FEBS Open Bio, 2014, 4: 777-787.
|
[5] |
Karunakaran D,Geoffrion M,Wei L, et al. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis[J]. Sci Adv, 2016, 2(7): e1600224.
|
[6] |
Xu Y,Wang J,Song X, et al. RIP3 induces ischemic neuronal DNA degradation and programmed necrosis in rat via AIF[J]. Sci Rep, 2016, 6: 29362.
|
[7] |
Kitur K,Wachtel S,Brown A, et al. Necroptosis promotes staphylococcus aureus clearance by inhibiting excessive inflammatory signaling[J]. Cell Rep, 2016, 16(8): 2219-2230.
|
[8] |
Bozec D,Iuga AC,Roda G, et al. Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis[J]. Oncotarget, 2016, 7(29): 46384-46400.
|
[9] |
Zhang DW,Shao J,Lin J, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis[J]. Science, 2009, 325(5938): 332-336.
|
[10] |
Su Z,Yang Z,Xie L, et al. Cancer therapy in the necroptosis era[J]. Cell Death Differ, 2016, 23(5): 748-756.
|
[11] |
Das A,McDonald DG,Dixon-Mah YN, et al. RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma[J]. Tumour Biol, 2016, 37(6): 7525-7534.
|
[12] |
Gerges S,Rohde K,Fulda S. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells[J]. Cancer Lett, 2016, 375(1): 127-132.
|
[13] |
Zaidi HA,Zabramski JM,Safavi-Abbasi S, et al. Spontaneous intracerebral hemorrhage[J]. World Neurosurg, 2015, 84(5): 1191-1192.
|
[14] |
Liu T,Bao YH,Wang Y, et al. The role of necroptosis in neurosurgical diseases[J]. Braz J Med Biol Res, 2015, 48(4): 292-298.
|
[15] |
Degterev A,Hitomi J,Germscheid M, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins[J]. Nat Chem Biol, 2008, 4(5): 313-321.
|
[16] |
Sun L,Wang H,Wang Z, et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase[J]. Cell, 2012, 148(1-2): 213-227.
|
[17] |
Galluzzi L,Kepp O,Kroemer G. MLKL regulates necrotic plasma membrane permeabilization[J]. Cell Res, 2014, 24(2): 139-140.
|
[18] |
He S,Wang L,Miao L, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha[J]. Cell, 2009, 137(6): 1100-1111.
|
[19] |
Liu T,Zhao DX,Cui H, et al. Therapeutic hypothermia attenuates tissue damage and cytokine expression after traumatic brain injury by inhibiting necroptosis in the rat[J]. Sci Rep, 2016, 6: 24547.
|
[20] |
Noshita N,Lewén A,Sugawara T, et al. Akt phosphorylation and neuronal survival after traumatic brain injury in mice[J]. Neurobiol Dis, 2002, 9(3): 294-304.
|
[21] |
Crino PB. The mTOR signalling cascade: paving new roads to cure neurological disease[J]. Nat Rev Neurol, 2016, 12(7): 379-392.
|
[22] |
Park J,Zhang J,Qiu J, et al. Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice[J]. J Cereb Blood Flow Metab, 2012, 32(2): 330-340.
|
[23] |
Liu Q,Qiu J,Liang M, et al. Akt and mTOR mediate programmed necrosis in neurons[J]. Cell Death Dis, 2014, 5: e1084.
|
[24] |
Günther C,Martini E,Wittkopf N, et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis[J]. Nature, 2011, 477(7364): 335-339.
|
[25] |
Kim JW,Choi EJ,Joe CO. Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP[J]. Oncogene, 2000, 19(39): 4491-4499.
|
[26] |
Challa S,Chan FK. Going up in flames: necrotic cell injury and inflammatory diseases[J]. Cell Mol Life Sci, 2010, 67(19): 3241-3253.
|
[27] |
Kaiser WJ,Sridharan H,Huang C, et al. Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL[J]. J Biol Chem, 2013, 288(43): 31268-31279.
|
[28] |
Wallach D,Kang TB,Dillon CP, et al. Programmed necrosis in inflammation: Toward identification of the effector molecules[J]. Science, 2016, 352(6281): aaf2154.
|
[29] |
Newton K,Manning G. Necroptosis and inflammation[J]. Annu Rev Biochem, 2016, 85: 743-763.
|
[30] |
Pasparakis M,Vandenabeele P. Necroptosis and its role in inflammation[J]. Nature, 2015, 517(7534): 311-320.
|
[31] |
Menu P,Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly[J]. Clin Exp Immunol, 2011, 166(1): 1-15.
|